Two nights of home polysomnography in healthy 7-14-year-old children - Feasibility and intraindividual variability.


Journal

Sleep medicine
ISSN: 1878-5506
Titre abrégé: Sleep Med
Pays: Netherlands
ID NLM: 100898759

Informations de publication

Date de publication:
01 2023
Historique:
received: 12 09 2022
revised: 24 10 2022
accepted: 26 10 2022
pubmed: 12 11 2022
medline: 11 1 2023
entrez: 11 11 2022
Statut: ppublish

Résumé

Attended polysomnography (PSG) is the gold standard for childhood sleep evaluation. There is, however, only limited information regarding repeated ambulatory PSG in children. We aimed to test whether in hospital attached level 2 home PSG is feasible and reproducible in healthy children. We recruited healthy children aged 7-14 years to undergo two nights of full level 2 PSG. The PSG equipment was attached at the hospital on the day of the sleep test and all recordings were performed at home. Subjective sleep quality, nocturnal urine production, sleep time and number of awakenings were documented for a week in connection to the first PSG night. Thirty-three children were recruited of whom 32 children (aged 11 ± 2.1 years) underwent two nights of PSG. All 64 PSGs were technically adequate for sleep evaluation. We found mean sleep efficiency of 94% and mean total sleep time of 8.4 h. Sleep stages distribution with 5.9% N1, 46.8% N2, 24.3% N3 and 22.8% REM sleep. We found poorer subjective sleep quality, more self-reported awakenings, and shorter total sleep time on nights with PSG compared to nights without PSG with no differences between PSG study nights. No differences in nocturnal urine production were found between nights with and without PSG. The comparison of PSG variables between the two PSG nights revealed no first night effect. Type 2 PSG recording is feasible for sleep evaluation in children 7-14 years of age producing good data quality. We found no first night effect on PSG variables. www. gov Registration number: NCT03477812.

Identifiants

pubmed: 36368073
pii: S1389-9457(22)01188-1
doi: 10.1016/j.sleep.2022.10.027
pii:
doi:

Banques de données

ClinicalTrials.gov
['NCT03477812']

Types de publication

Clinical Study Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

87-92

Informations de copyright

Copyright © 2022 The Authors. Published by Elsevier B.V. All rights reserved.

Auteurs

Malthe Jessen Pedersen (MJ)

Department of Pediatrics and Adolescent Medicine, Aarhus University Hospital, Denmark. Electronic address: Maltpe@rm.dk.

Helle Leonthin (H)

Danish Center for Sleep Medicine, Department of Clinical Neurophysiology, Rigshospitalet, Glostrup, Denmark.

Birgitte Mahler (B)

Department of Pediatrics and Adolescent Medicine, Aarhus University Hospital, Denmark.

Søren Rittig (S)

Department of Pediatrics and Adolescent Medicine, Aarhus University Hospital, Denmark.

Poul Jørgen Jennum (PJ)

Danish Center for Sleep Medicine, Department of Clinical Neurophysiology, Rigshospitalet, Glostrup, Denmark.

Konstantinos Kamperis (K)

Department of Pediatrics and Adolescent Medicine, Aarhus University Hospital, Denmark.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH